First Trust NYSE Arca Biotechnology ETF (FBT)

First Trust NYSE Arca Biotechnology ETF (FBT $27.57)
- $27.57 P/E (TTM): 17.7X Cap: $1M
- View FBT Profile
- View Questions on FBT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Biogen Inc. (BIIB $125.15)
- $125.15 P/E (TTM): 12.12X Cap: $17.97B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $109.26)
- $109.26 P/E (TTM): 22.75X Cap: $134.69B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $98.31)
- $98.31 Cap: $15B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $186.74)
- $186.74 P/E (TTM): 79.0X Cap: $326.51B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $125.91)
- $125.91 P/E (TTM): 16.16X Cap: $216.47B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $772.60)
- $772.60 P/E (TTM): 62.79X Cap: $722.34B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $66.19)
- $66.19 P/E (TTM): 18.31X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $131.45)
- $131.45 P/E (TTM): 41.5X Cap: $5.30B
- View IBB Profile
- View Questions on IBB
SPDR Biotech ETF (XBI $85.68)
- $85.68 P/E (TTM): 25.15X Cap: $4.94B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $27.57)
- $27.57 P/E (TTM): 17.7X Cap: $1M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025